Manodeep Sen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Manodeep Sen has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Anupam Das
Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
8 shared publications- Jyotsna Agarwal
Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
7 shared publications - Anupam Das
Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
6 shared publications Jyotsna Agarwal
Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
6 shared publicationsTanushri Chatterji
PhD (Reader), Dept. of Microbiology, Babu Banarasi Das College of Dental Sciences, Babu Banarasi Das University, Lucknow-226028, India
5 shared publications- Vikramjeet Singh
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow
5 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (02) , 271-277
Procalcitonin: the bacterial and non-bacterial sepsis marker
Introduction: The aim of this study was to evaluate the role of procalcitonin (PCT) in differentiating causative agents of bacterial sepsis, and sepsis from non-bacterial causes (viral, fungal, and parasitic). Methodology: This study was conducted in the Department of Microbiology (April 2023 to March 2024) and included 1,346 clinically suspected cases of bacterial, fungal, viral, and parasitic infections confirmed through various diagnostic methods. Serum/plasma samples were collected from the participants and healthy controls, and PCT levels were measured. PCT concentration of < 2 ng/mL was classified as low, while levels ≥ 2 ng/mL were considered high, serving as threshold for sepsis diagnosis. Results: PCT levels were significantly higher in sepsis caused by Gram-negative bacteria compared to Gram-positive bacteria, and showed a notable increase in Plasmodium infections (p < 0.0001). No significant association was observed between PCT levels and Candida albicans infections; however, cases involving non-albicans Candida species showed significantly elevated PCT levels (p = 0.0265). Infections with Cryptococcal species, hepatitis B, and hepatitis C showed a marked decrease in PCT levels. PCT levels were low in all cases involving skin commensals, with a more pronounced reduction in the case of coagulase-negative Staphylococcus compared to diphtheroids. Conclusions: PCT levels showed a significant elevation in infections caused by non-bacterial agents, including Plasmodium and non-albicans Candida. A notable decline in PCT levels was observed in systemic infections caused by viruses and Cryptococcus. PCT is emerging as a universal biomarker for both bacterial and non-bacterial sepsis, making it a potential universal marker for sepsis.
- 28 February 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (02) , 271-277
Open AccessProcalcitonin: the bacterial and non-bacterial sepsis marker
Introduction: The aim of this study was to evaluate the role of procalcitonin (PCT) in differentiating causative agents of bacterial sepsis, and sepsis from non-bacterial causes (viral, fungal, and parasitic). Methodology: This study was conducted in the Department of Microbiology (April 2023 to March 2024) and included 1,346 clinically suspected cases of bacterial, fungal, viral, and parasitic infections confirmed through various diagnostic methods. Serum/plasma samples were collected from the participants and healthy controls, and PCT levels were measured. PCT concentration of < 2 ng/mL was classified as low, while levels ≥ 2 ng/mL were considered high, serving as threshold for sepsis diagnosis. Results: PCT levels were significantly higher in sepsis caused by Gram-negative bacteria compared to Gram-positive bacteria, and showed a notable increase in Plasmodium infections (p < 0.0001). No significant association was observed between PCT levels and Candida albicans infections; however, cases involving non-albicans Candida species showed significantly elevated PCT levels (p = 0.0265). Infections with Cryptococcal species, hepatitis B, and hepatitis C showed a marked decrease in PCT levels. PCT levels were low in all cases involving skin commensals, with a more pronounced reduction in the case of coagulase-negative Staphylococcus compared to diphtheroids. Conclusions: PCT levels showed a significant elevation in infections caused by non-bacterial agents, including Plasmodium and non-albicans Candida. A notable decline in PCT levels was observed in systemic infections caused by viruses and Cryptococcus. PCT is emerging as a universal biomarker for both bacterial and non-bacterial sepsis, making it a potential universal marker for sepsis.
- Open Access
- 31 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1) , e102696
Prevalence, Antimicrobial Resistance, and Molecular Characterization of Vancomycin-Resistant Enterococci in a North Indian Tertiary Care Hospital
Background Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens with limited treatment options and increasing prevalence in India. This study aimed to determine the prevalence of VRE among hospitalized adults, evaluate their antimicrobial resistance patterns, and characterize genetic determinants of vancomycin resistance. Methods A cross-sectional study was conducted from April 2023 to September 2024. Enterococcus spp. isolated from adult inpatients were identified using standard methods and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial susceptibility testing was performed by Kirby-Bauer disc diffusion and Epsilometer strip minimum inhibitory concentration (E-strip MIC) testing. A subset of isolates underwent multiplex real-time polymerase chain reaction (PCR) for vanA and vanB gene detection. Results Of 3,176 Enterococcus isolates, 234 (7.36%) were VRE. Urine samples accounted for 210/2,684 (7.8%) and blood cultures for 12/210 (5.7%) of VRE isolates. Overall, Enterococcus faecalis (E. faecalis) (1,960; 61.7%) predominated, while Enterococcus faecium (E. faecium) (1,216; 38.3%) showed higher resistance. Among VRE, E. faecalis contributed 145/234 (61.9%) and E. faecium 89/234 (38.0%). All VRE were resistant to vancomycin (MIC ≥32 µg/mL). Linezolid was effective against all isolates (234/234; 100%). Molecular analysis of 20 representative isolates confirmed the presence of vanA in all (100%), with no vanB detected. Conclusion A 7.36% prevalence of VRE was observed, predominantly in urinary and bloodstream infections. Exclusive detection of vanA indicates clonal dissemination of high-level resistance. Routine species-level identification, antimicrobial stewardship, and molecular surveillance are critical to limiting VRE spread in tertiary care settings.
- 31 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1) , e102696
Open AccessPrevalence, Antimicrobial Resistance, and Molecular Characterization of Vancomycin-Resistant Enterococci in a North Indian Tertiary Care Hospital
Background Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens with limited treatment options and increasing prevalence in India. This study aimed to determine the prevalence of VRE among hospitalized adults, evaluate their antimicrobial resistance patterns, and characterize genetic determinants of vancomycin resistance. Methods A cross-sectional study was conducted from April 2023 to September 2024. Enterococcus spp. isolated from adult inpatients were identified using standard methods and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial susceptibility testing was performed by Kirby-Bauer disc diffusion and Epsilometer strip minimum inhibitory concentration (E-strip MIC) testing. A subset of isolates underwent multiplex real-time polymerase chain reaction (PCR) for vanA and vanB gene detection. Results Of 3,176 Enterococcus isolates, 234 (7.36%) were VRE. Urine samples accounted for 210/2,684 (7.8%) and blood cultures for 12/210 (5.7%) of VRE isolates. Overall, Enterococcus faecalis (E. faecalis) (1,960; 61.7%) predominated, while Enterococcus faecium (E. faecium) (1,216; 38.3%) showed higher resistance. Among VRE, E. faecalis contributed 145/234 (61.9%) and E. faecium 89/234 (38.0%). All VRE were resistant to vancomycin (MIC ≥32 µg/mL). Linezolid was effective against all isolates (234/234; 100%). Molecular analysis of 20 representative isolates confirmed the presence of vanA in all (100%), with no vanB detected. Conclusion A 7.36% prevalence of VRE was observed, predominantly in urinary and bloodstream infections. Exclusive detection of vanA indicates clonal dissemination of high-level resistance. Routine species-level identification, antimicrobial stewardship, and molecular surveillance are critical to limiting VRE spread in tertiary care settings.
- Open Access
- 1 September 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (9) , 001024.v3
A prospective study on the evaluation of a novel immunochromatographic card for the rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producers
Objective. To evaluate the performance of a novel immunochromatographic (IC) card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL)-producing organisms, compared to real-time PCR and an Advanced Expert System (AES). Methods. Clinically isolated 100 non-duplicates of multidrug-resistant Gram-negative bacilli expressing MBL production were tested using the novel IC card, real-time PCR and the Vitek-2 AES. Sensitivity, specificity and turnaround time were evaluated. Results. The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%) and IMP (33%) compared to PCR. It had a rapid turnaround time of 15–20 min versus 5–7 h for PCR and 18–22 h for AES. Conclusion. The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Considering the limited sensitivity for the IMP and VIM genes, this warrants confirmatory testing by PCR. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks.
- 1 September 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (9) , 001024.v3
Open AccessA prospective study on the evaluation of a novel immunochromatographic card for the rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producers
Objective. To evaluate the performance of a novel immunochromatographic (IC) card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL)-producing organisms, compared to real-time PCR and an Advanced Expert System (AES). Methods. Clinically isolated 100 non-duplicates of multidrug-resistant Gram-negative bacilli expressing MBL production were tested using the novel IC card, real-time PCR and the Vitek-2 AES. Sensitivity, specificity and turnaround time were evaluated. Results. The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%) and IMP (33%) compared to PCR. It had a rapid turnaround time of 15–20 min versus 5–7 h for PCR and 18–22 h for AES. Conclusion. The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Considering the limited sensitivity for the IMP and VIM genes, this warrants confirmatory testing by PCR. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks.
- Open Access
- 14 August 2025
- Published by Microbiology Society
- p. 001024.v2
A prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.
Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.
- 14 August 2025
- Published by Microbiology Society
- p. 001024.v2
Open AccessA prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.
Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.
- Open Access
- 24 March 2025
- Published by Scientific Scholar in Journal of Laboratory Physicians
- Vol. 17, 81-87
Observation of matrix metalloproteinase-9 levels in patients with neurocysticercosis at a tertiary care super specialty institute in North India
Objectives: Elevated levels of matrix metalloproteinase-9 (MMP-9) in both serum and cerebrospinal fluid have been observed in patients diagnosed with cysticercus granuloma. These elevated levels significantly contribute to the onset of symptoms, such as active seizures, in patients with neurocysticercosis (NCC). This study aimed to compare and correlate MMP-9 levels between NCC cases and control subjects. Materials and Methods: In this prospective case-control study, 45 symptomatic cases of NCC and 30 controls were enrolled. Serum MMP-9 levels were measured using a commercially procured enzyme-linked immunosorbent assay kit (QayeeBio, Shanghai, China) in all collected serum samples, following the manufacturer’s instructions. Statistical analysis: Data were presented as mean ± standard deviation (SD), frequencies, and percentages. Chi-square and unpaired t-tests were used for comparisons, while receiver operating curve analysis was performed to assess diagnostic accuracy metrics, with a significance threshold of P < 0.05. Results: The mean age of cases and controls was 31.20 ± 11.98 years and 55.40 ± 9.80 years, respectively. The mean ± SD values of MMP-9 were significantly higher in NCC cases (13.42 ± 5.70 ng/mL) compared to controls (8.49 ± 4.21 ng/mL) (P < 0.00001). At a cutoff of >10 ng/mL, serum MMP-9 levels correctly identified 73.3% of the 45 confirmed NCC cases (33/45; sensitivity) and correctly excluded 63.3% of the 30 controls (19/30; specificity). This threshold resulted in a positive predictive value of 75.0% and a negative predictive value of 61.3%. Conclusions: MMP-9 demonstrated the ability to distinguish NCC cases from controls with a sensitivity of >73% and may serve as a marker for predicting and diagnosing symptomatic NCC. However, due to its moderate sensitivity and specificity, MMP-9 should not be used as a standalone diagnostic marker. Instead, it may complement existing serological and imaging tools to diagnose NCC.
- 24 March 2025
- Published by Scientific Scholar in Journal of Laboratory Physicians
- Vol. 17, 81-87
Open AccessObservation of matrix metalloproteinase-9 levels in patients with neurocysticercosis at a tertiary care super specialty institute in North India
Objectives: Elevated levels of matrix metalloproteinase-9 (MMP-9) in both serum and cerebrospinal fluid have been observed in patients diagnosed with cysticercus granuloma. These elevated levels significantly contribute to the onset of symptoms, such as active seizures, in patients with neurocysticercosis (NCC). This study aimed to compare and correlate MMP-9 levels between NCC cases and control subjects. Materials and Methods: In this prospective case-control study, 45 symptomatic cases of NCC and 30 controls were enrolled. Serum MMP-9 levels were measured using a commercially procured enzyme-linked immunosorbent assay kit (QayeeBio, Shanghai, China) in all collected serum samples, following the manufacturer’s instructions. Statistical analysis: Data were presented as mean ± standard deviation (SD), frequencies, and percentages. Chi-square and unpaired t-tests were used for comparisons, while receiver operating curve analysis was performed to assess diagnostic accuracy metrics, with a significance threshold of P < 0.05. Results: The mean age of cases and controls was 31.20 ± 11.98 years and 55.40 ± 9.80 years, respectively. The mean ± SD values of MMP-9 were significantly higher in NCC cases (13.42 ± 5.70 ng/mL) compared to controls (8.49 ± 4.21 ng/mL) (P < 0.00001). At a cutoff of >10 ng/mL, serum MMP-9 levels correctly identified 73.3% of the 45 confirmed NCC cases (33/45; sensitivity) and correctly excluded 63.3% of the 30 controls (19/30; specificity). This threshold resulted in a positive predictive value of 75.0% and a negative predictive value of 61.3%. Conclusions: MMP-9 demonstrated the ability to distinguish NCC cases from controls with a sensitivity of >73% and may serve as a marker for predicting and diagnosing symptomatic NCC. However, due to its moderate sensitivity and specificity, MMP-9 should not be used as a standalone diagnostic marker. Instead, it may complement existing serological and imaging tools to diagnose NCC.
- Open Access
- 21 March 2025
- Published by Microbiology Society
- p. 001024.v1
A prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.
Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.
- 21 March 2025
- Published by Microbiology Society
- p. 001024.v1
Open AccessA prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.
Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.
- Open Access
- 15 October 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (10) , 243
A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis
Schistosomiasis, which affects a large number of people worldwide, is among the most overlooked parasitic diseases. The disease is mainly prevalent in sub-Saharan Africa, southeast Asian countries, and South America due to the lack of adequate sanitation. The disease is mainly associated with poor hygiene, sanitation, and contaminated water, so it is also known as a disease of poverty. Three Schistosoma species (S. mansoni, S. japonicum, and S. haematobium) cause significant human infections. Co-infections with Schistosoma and other parasites are widely common. All these parasites may cause intestinal or urogenital schistosomiasis, where the disease may be categorized into the acute, sensitized, and chronic phases. The disease is more prevalent among school children, which may cause anemia and reduce development. Chronic infections frequently cause significant liver, intestinal, and bladder damage. Women exposed to contaminated water while performing normal duties like washing clothes might acquire urogenital schistosomiasis (UGS), which can cause tissue damage and raise the risk of blood-borne disease transmission, including human immunodeficiency virus (HIV) transmission. Praziquantel (PZQ) is the World Health Organization (WHO)-prescribed treatment for individuals who are known to be infected, but it does not prevent further re-infections with larval worms. Vaccine development and new molecular-based diagnosis techniques have promised to be a reliable approach to the diagnosis and prevention of schistosomiasis. The current review emphasizes the recent advancement in the diagnosis of schistosomiasis by molecular techniques and the treatment of schistosomiasis by combined and alternative regimes of drugs. Moreover, this review has also focused on the recent outbreak of schistosomiasis, the development of vaccines, and their clinical trials.
- 15 October 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (10) , 243
Open AccessA Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis
Schistosomiasis, which affects a large number of people worldwide, is among the most overlooked parasitic diseases. The disease is mainly prevalent in sub-Saharan Africa, southeast Asian countries, and South America due to the lack of adequate sanitation. The disease is mainly associated with poor hygiene, sanitation, and contaminated water, so it is also known as a disease of poverty. Three Schistosoma species (S. mansoni, S. japonicum, and S. haematobium) cause significant human infections. Co-infections with Schistosoma and other parasites are widely common. All these parasites may cause intestinal or urogenital schistosomiasis, where the disease may be categorized into the acute, sensitized, and chronic phases. The disease is more prevalent among school children, which may cause anemia and reduce development. Chronic infections frequently cause significant liver, intestinal, and bladder damage. Women exposed to contaminated water while performing normal duties like washing clothes might acquire urogenital schistosomiasis (UGS), which can cause tissue damage and raise the risk of blood-borne disease transmission, including human immunodeficiency virus (HIV) transmission. Praziquantel (PZQ) is the World Health Organization (WHO)-prescribed treatment for individuals who are known to be infected, but it does not prevent further re-infections with larval worms. Vaccine development and new molecular-based diagnosis techniques have promised to be a reliable approach to the diagnosis and prevention of schistosomiasis. The current review emphasizes the recent advancement in the diagnosis of schistosomiasis by molecular techniques and the treatment of schistosomiasis by combined and alternative regimes of drugs. Moreover, this review has also focused on the recent outbreak of schistosomiasis, the development of vaccines, and their clinical trials.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 30-34
Proton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults
Cystic echinococcosis (CE) is a parasitic zoonosis caused by the tapeworm Echinococcus granulosus. Over the past few years, a lot of research has been done on liver illnesses using metabolomics techniques to identify biomarkers which could identify the diseases in its early stages. The present study was done to explore biomarkers in serum, urine, and cystic fluid which would help in differentiating, staging, and assessing fertility of intra-abdominal hydatid cyst by using proton nuclear magnetic resonance (1H NMR) metabolomics. In the study, 28 subjects (16 cases and 12 controls) were enrolled. Staging of hydatid cysts was performed using ultrasonography. In patients complying with case and control definition, blood, urine, and cystic fluid were collected for complete blood count, urine culture, Echinococcus IgG enzyme-linked immunosorbent assay (ELISA), and metabolomic analysis. The 17, 15, and 11 metabolites in serum, urine, and cystic fluid samples were quantified, respectively, to differentiate between case and control group. In this study, we observed that there was a significant downregulation of succinate metabolite in urine samples of cases, down-regulation of five metabolites (isoleucine, valine, histidine, tyrosine and formate) and upregulation of alanine in cystic fluid of cases. Current study demonstrates that metabolomics can be used non-invasively for rapid diagnosis of CE. This is one of the very few studies, which used 1H NMR spectroscopy, to analyze the profile of metabolites in serum, urine, and cystic fluid in cases of CE and controls. Raj N, Pandey A, Roy R, et al. Proton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults. Euroasian J Hepato-Gastroenterol 2024;14(1):30–34.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 30-34
Open AccessProton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults
Cystic echinococcosis (CE) is a parasitic zoonosis caused by the tapeworm Echinococcus granulosus. Over the past few years, a lot of research has been done on liver illnesses using metabolomics techniques to identify biomarkers which could identify the diseases in its early stages. The present study was done to explore biomarkers in serum, urine, and cystic fluid which would help in differentiating, staging, and assessing fertility of intra-abdominal hydatid cyst by using proton nuclear magnetic resonance (1H NMR) metabolomics. In the study, 28 subjects (16 cases and 12 controls) were enrolled. Staging of hydatid cysts was performed using ultrasonography. In patients complying with case and control definition, blood, urine, and cystic fluid were collected for complete blood count, urine culture, Echinococcus IgG enzyme-linked immunosorbent assay (ELISA), and metabolomic analysis. The 17, 15, and 11 metabolites in serum, urine, and cystic fluid samples were quantified, respectively, to differentiate between case and control group. In this study, we observed that there was a significant downregulation of succinate metabolite in urine samples of cases, down-regulation of five metabolites (isoleucine, valine, histidine, tyrosine and formate) and upregulation of alanine in cystic fluid of cases. Current study demonstrates that metabolomics can be used non-invasively for rapid diagnosis of CE. This is one of the very few studies, which used 1H NMR spectroscopy, to analyze the profile of metabolites in serum, urine, and cystic fluid in cases of CE and controls. Raj N, Pandey A, Roy R, et al. Proton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults. Euroasian J Hepato-Gastroenterol 2024;14(1):30–34.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 60-64
Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India
Healthcare-associated diarrhea (HCAD) is diarrhea that develops at least after 3 days of hospitalization, with the most common infectious cause being Clostridioides difficile. Over the last decade, there has been a remarkable growth in the frequency and severity of C. difficile infection (CDI), making it one of the most prevalent healthcare-associated infections. This study aimed to analyze the prevalence and risk factors associated with CDI. A total of 107 patients with clinical suspicion of having HCAD were included in this study. Enzyme-linked fluorescent assay (ELFA) technique-based glutamate dehydrogenase (GDH) and toxin A/B assay were used as per the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for diagnosing CDI. The details about associated comorbidities were retrieved from the hospital information system records. The presence of risk factors was noted. Risk factors associated with CDI were looked for. Out of the 107 stool samples received in the microbiology laboratory from patients with suspected HCAD eight (7.6%) samples were positive for CDI. The most frequent comorbidity observed in these patients was renal illness (acute or chronic kidney disease). In this study, a total of 7/8 cases were on multiple antibiotics most common being carbapenem. The 6-year prevalence of CDI observed in this study was found to be 7.6% risk factors, associated with CDI were kidney disease, diabetes mellitus, malignancy, and exposure to broad-spectrum antibiotics. Raj N, Agarwal J, Singh V, et al. Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(1):60–64.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 60-64
Open AccessHealthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India
Healthcare-associated diarrhea (HCAD) is diarrhea that develops at least after 3 days of hospitalization, with the most common infectious cause being Clostridioides difficile. Over the last decade, there has been a remarkable growth in the frequency and severity of C. difficile infection (CDI), making it one of the most prevalent healthcare-associated infections. This study aimed to analyze the prevalence and risk factors associated with CDI. A total of 107 patients with clinical suspicion of having HCAD were included in this study. Enzyme-linked fluorescent assay (ELFA) technique-based glutamate dehydrogenase (GDH) and toxin A/B assay were used as per the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for diagnosing CDI. The details about associated comorbidities were retrieved from the hospital information system records. The presence of risk factors was noted. Risk factors associated with CDI were looked for. Out of the 107 stool samples received in the microbiology laboratory from patients with suspected HCAD eight (7.6%) samples were positive for CDI. The most frequent comorbidity observed in these patients was renal illness (acute or chronic kidney disease). In this study, a total of 7/8 cases were on multiple antibiotics most common being carbapenem. The 6-year prevalence of CDI observed in this study was found to be 7.6% risk factors, associated with CDI were kidney disease, diabetes mellitus, malignancy, and exposure to broad-spectrum antibiotics. Raj N, Agarwal J, Singh V, et al. Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(1):60–64.
- Open Access
- 1 July 2023
- Published by Medknow in MGM Journal of Medical Sciences
- Vol. 10 (3) , 524-529
Seroprevalence of Echinococcus IgG antibodies in a tertiary care center: a 5-year study and literature review
Background: Cystic echinococcosis (CE), also known as hydatid disease, is a global zoonotic infection resulting from the larval stage of Echinococcus granulosus tapeworms. This condition manifests as single or multiple cystic growths in various bodily organs such as the liver, lungs, kidneys, etc. Materials and Methods: A retrospective analysis was conducted on all sample records within the microbiology laboratory register or microbiology database of the parasitology section, spanning from January 2017 to December 2021. The objective was to ascertain the seroprevalence of echinococcosis. Through enzyme-linked immune sorbent assay, 200 samples were examined to detect the presence of anti-hydatid immunoglobulin G (IgG). Results: Among the individuals tested for CE IgG antibodies, a greater seroprevalence was evident in female patients (42.7%) compared to males (32.5%). In 2017, the observed seroprevalence stood at 36%; in 2021, it escalated to 55.5%. It signifies a noteworthy surge of 20% in seropositivity over the last 5 years. Conclusion: The study’s findings highlight a substantial correlation between age, gender, and the prevalence of CE in northern India. Furthermore, the research revealed a progressive incline in seropositivity rates among patients from North India.
- 1 July 2023
- Published by Medknow in MGM Journal of Medical Sciences
- Vol. 10 (3) , 524-529
Open AccessSeroprevalence of Echinococcus IgG antibodies in a tertiary care center: a 5-year study and literature review
Background: Cystic echinococcosis (CE), also known as hydatid disease, is a global zoonotic infection resulting from the larval stage of Echinococcus granulosus tapeworms. This condition manifests as single or multiple cystic growths in various bodily organs such as the liver, lungs, kidneys, etc. Materials and Methods: A retrospective analysis was conducted on all sample records within the microbiology laboratory register or microbiology database of the parasitology section, spanning from January 2017 to December 2021. The objective was to ascertain the seroprevalence of echinococcosis. Through enzyme-linked immune sorbent assay, 200 samples were examined to detect the presence of anti-hydatid immunoglobulin G (IgG). Results: Among the individuals tested for CE IgG antibodies, a greater seroprevalence was evident in female patients (42.7%) compared to males (32.5%). In 2017, the observed seroprevalence stood at 36%; in 2021, it escalated to 55.5%. It signifies a noteworthy surge of 20% in seropositivity over the last 5 years. Conclusion: The study’s findings highlight a substantial correlation between age, gender, and the prevalence of CE in northern India. Furthermore, the research revealed a progressive incline in seropositivity rates among patients from North India.